ARDELYX, INC. Earnings Per Share, Basic and Diluted
ARDELYX, INC. (ARDX) reported Earnings Per Share, Basic and Diluted of -$0.32 per share for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-03-08
- ARDELYX, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.32.
- ARDELYX, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.20.
- ARDELYX, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.28.
- ARDELYX, INC. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.25.
- ARDELYX, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.05.
- ARDELYX, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.47.
- ARDELYX, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.62.
- ARDELYX, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.36.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$0.32 10-K · filed 2021-03-08 | -$1.05 10-K · filed 2021-03-08 | ||
| 2020-09-30 | -$0.20 10-K · filed 2021-03-08 | -$0.73 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | -$0.28 10-K · filed 2021-03-08 | -$0.53 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | -$0.25 10-K · filed 2021-03-08 | |||
| 2019-12-31 | -$0.27 10-K · filed 2021-03-08 | -$1.47 10-K · filed 2021-03-08 | ||
| 2019-09-30 | -$0.37 10-K · filed 2021-03-08 | -$1.20 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | -$0.41 10-K · filed 2021-03-08 | -$0.82 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$0.42 10-K · filed 2021-03-08 | |||
| 2018-12-31 | -$0.45 10-K · filed 2020-03-06 | -$1.62 10-K · filed 2021-03-08 | ||
| 2018-09-30 | -$0.39 10-K · filed 2020-03-06 | -$1.17 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | -$0.42 10-K · filed 2020-03-06 | -$0.78 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | -$0.36 10-K · filed 2020-03-06 | |||
| 2017-12-31 | -$1.36 10-K · filed 2020-03-06 | |||
| 2017-09-30 | -$0.44 10-Q · filed 2018-11-07 | -$1.57 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$0.54 10-Q · filed 2018-08-07 | -$1.13 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$0.59 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | -$0.66 10-K · filed 2018-03-14 | -$2.80 10-K · filed 2019-03-06 | ||
| 2016-09-30 | -$0.65 10-K · filed 2018-03-14 | -$2.15 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$0.83 10-K · filed 2018-03-14 | -$1.53 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$0.70 10-K · filed 2018-03-14 | |||
| 2015-12-31 | -$1.29 10-K · filed 2018-03-14 | |||
| 2015-09-30 | -$0.70 10-Q · filed 2016-11-07 | -$0.58 10-Q · filed 2016-11-07 | ||
| 2015-03-31 | -$0.19 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | -$0.31 10-K · filed 2017-02-17 | |||
| 2014-03-31 | -$2.44 10-Q · filed 2015-05-12 | |||
| 2013-12-31 | -$3.53 10-K · filed 2015-03-05 | -$5.82 10-K · filed 2016-03-04 | ||
| 2013-09-30 | -$0.81 10-K · filed 2015-03-05 | |||
| 2013-06-30 | -$0.81 10-K · filed 2015-03-05 | |||
| 2013-03-31 | -$0.45 10-K · filed 2015-03-05 | |||
| 2012-12-31 | -$11.32 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |